Hospitals charge, on average, 500% of their acquisition cost for 20 individual medicines that account for the largest share of [...] …
Category: Pharma Industry
Drug manufacturer Merck recently loosened its 340B program contract pharmacy restrictions in Louisiana and Arkansas just before Louisiana’s law protecting [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Today is the first day of Louisiana’s new law protecting 340B program contract pharmacy arrangements and there have already been [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Health Resources and Services Administration (HRSA) this week published notices from drug makers Amgen and Vertex about refunds [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Biopharmaceutical manufacturer Genentech, South Dakota-based health system Sanford Health, and South Carolina federally qualified health center Carolina Health Centers are jointly lobbying members of Congress to back six U.S. senators’ bipartisan approach to federal 340B program reform, the three organizations
…
Generic drug manufacturer Amring Pharmaceuticals is giving 340B covered entities refunds for overcharges on 14 products between the first quarter [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturers Johnson & Johnson and Astellas Pharma have each asked federal district courts to strike down parts of the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Generic and over-the-counter drug manufacturer VistaPharm said in a public notice this week that it has identified 340B covered entities [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturers Astellas and AstraZeneca announced today separate contract pharmacy policies for 340B providers that will go into effect in [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
ASAP 340B, the nonprofit group that the brand drug industry and health centers formed to help advance the two sides’ joint plan to remake the 340B program, held its first webinar yesterday to describe its policy principles and call for
…